Generic Name:

tetanus-toxoid, Injectable Suspension

All Brands

SECTION 1 of 4

Highlights for tetanus-toxoid

Injectable Suspension
TETANUS TOXOID (TET n uhs tok soid) is a vaccine. It is used to prevent infections of tetanus (lockjaw).
2 3 4
Talk to your healthcare provider if you have any of these conditions.
Know what to watch for and get tips for reducing your risks while taking this drug.
SECTION 2 of 4

tetanus-toxoid Side Effects

Injectable Suspension

Side effects that you should report to your doctor or health care professional as soon as possible:

  • allergic reactions like skin rash, itching or hives, swelling of the face, lips, or tongue
  • arthritis pain
  • breathing problems
  • extreme changes in behavior
  • fast, irregular heartbeat
  • fever over 100 degrees F
  • pain, tingling, numbness in the hands or feet
  • seizures
  • unusually weak or tired

Side effects that usually do not require medical attention (report to your doctor or health care professional if they continue or are bothersome):

  • aches or pains
  • bruising, pain, swelling at site where injected
  • low-grade fever of 100 degrees F or less
  • nausea
SECTION 3 of 4

tetanus-toxoid May Interact with Other Medications

Injectable Suspension
  • adalimumab
  • anakinra
  • infliximab
  • medicines that suppress your immune system
  • medicines to treat cancer
  • steroid medicines like prednisone or cortisone
Disclaimer: Our goal is to provide you with the most relevant and current information. However, because drugs interact differently in each person, we cannot guarantee that this information includes all possible interactions. This information is not a substitute for medical advice. Always speak with your healthcare provider about possible interactions with all prescription drugs, vitamins, herbs and supplements, and over-the-counter drugs that you are taking.
SECTION 4 of 4

How to Use tetanus-toxoid

Injectable Suspension

This vaccine is for injection into a muscle. It is given by a health care professional.

A copy of Vaccine Information Statements will be given before each vaccination. Read this sheet carefully each time. The sheet may change frequently.

Talk to your pediatrician regarding the use of this medicine in children. While this drug may be prescribed for children as young as 7 years of age for selected conditions, precautions do apply.

What should I tell my health care provider before I take this medicine?

They need to know if you have any of these conditions:

  • bleeding disorder
  • immune system problems
  • infection with fever
  • low levels of platelets in the blood
  • an unusual or allergic reaction to tetanus toxoid, vaccines, latex, thimerosal, aluminium, other medicines, foods, dyes, or preservatives
  • pregnant or trying to get pregnant
  • breast-feeding
What if I miss a dose?

Keep appointments for follow-up (booster) doses as directed. It is important not to miss your dose. Call your doctor or health care professional if you are unable to keep an appointment.

What should I watch for while using this medicine?

Report any adverse reaction following administration to your health care provider. Contact your doctor or health care professional and seek emergency medical care if any serious side effects occur.

This vaccine, like all vaccines, may not fully protect everyone.

Where should I keep my medicine?

This drug is given in a hospital or clinic and will not be stored at home.

Last Updated: September 3, 2009

The Healthline Site, its content, such as text, graphics, images, search results, and other material contained on the Healthline Site ("Content"), its services, and any information or material posted on the Healthline Site by third parties are provided for informational purposes only. None of the foregoing is a substitute for professional medical advice, examination, diagnosis, or treatment. Always seek the advice of a physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on the Healthline Site. If you think you may have a medical emergency, call your doctor or 911 immediately. Please read the Terms of Service for more information regarding use of the Healthline Site.
Content licensed by
Gold Standard Logo

Healthline - Gold Standard License

Terms of Use

Licensee provides access to Alchemy provided by Gold Standard, Inc. ("Gold Standard"). Although Gold Standard makes reasonable efforts to ensure the accuracy and reliability of Alchemy, End User acknowledges and agrees that Licensee, its affiliates, and their respective officers, directors, employees and information providers and Gold Standard, its affiliates, its licensors, and their respective officers, directors, employees and information providers will not be held liable for any damages suffered or incurred by End User or any third person arising out of: a) any faults, interruptions or delays in Alchemy or its delivery, b) any use of or reliance on Alchemy by any person, or c) any inaccuracies, errors or omissions in Alchemy, irrespective of however such faults, interruptions, delays, inaccuracies, errors or omissions arise. Gold Standard shall not be liable to End User for any loss, cost or damages resulting from any delays in delivery and/or non-delivery of Alchemy or its content. End User acknowledges and agrees that its sole and exclusive remedy in the event of such delay is to not accept these terms and conditions. Gold Standard does not represent or warrant that Alchemy will meet the objectives or needs of End User or any third party. Gold Standard makes no warranty of merchantability of Alchemy or of the fitness of Alchemy for any purpose.

About Gold Standard

The Gold Standard editorial staff develops clinically-based drug information content through an independent, peer-reviewed process. Content updates to the database include new FDA-approved drugs, new non-prescription and herbal therapies, newly published information regarding FDA label changes and relevant clinical studies affecting off-label utilization. Editors do not have any significant financial relationships with the industry that would introduce bias in the editing or review of database content.